Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1990-06-18
1992-02-04
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514557, A61K 31215, A61K 3119
Patent
active
050860720
ABSTRACT:
A method is disclosed for the treatment of mood disorders, including major depression, by administering an effective mood disorder treating amount of a compound possessing functional antagonist properties for the N-methyl-D-aspartate receptor complex.
REFERENCES:
Foster, A. C. et al., Nature, vol. 329, 395-396 (1987).
Kleckner et al, Science, vol. 241, 835-837 (1988).
Marvizon et al, J. Neurochem., vol. 52, 992-994 (1989).
Olney, J. B. Biol. Psychiatry, vol. 26, 505-525 (1989).
Skolnick et al, Life Sciences, vol. 45, 1647-1655 (1989).
Trullas et al, Europ. Journ. of Pharmac., vol. 185, 1-10 (1990).
Skolnick Phil
Trullas Ramon
The United States of America as represented by the Department of
Waddell Frederick E.
Wilson Terry L.
LandOfFree
Treatment of mood disorders with functional antagonists of the g does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of mood disorders with functional antagonists of the g, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of mood disorders with functional antagonists of the g will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-348244